Search results
Results from the WOW.Com Content Network
The Sackler family is an American family who owned the pharmaceutical company Purdue Pharma and later founded Mundipharma. [1] Purdue Pharma, and some members of the family, have faced lawsuits regarding overprescription of addictive pharmaceutical drugs, including OxyContin .
Patrick Radden Keefe (born 1976) is an American writer and investigative journalist. [1] He is the author of five books—Chatter, The Snakehead, Say Nothing, Empire of Pain, and Rogues—and has written extensively for many publications, including The New Yorker, Slate, and The New York Times Magazine.
The book examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the family's central role in the opioid epidemic. [ 1 ] [ 2 ] [ 3 ] The book followed Keefe's 2017 article on the Sackler family in The New Yorker , titled "The Family That Built an Empire of Pain".
If approved, Purdue Pharma will contribute $900 million upfront while the Sackler family pays $6.5 billion over the next 15 years – a $500 million increase from the previous settlement.
Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an ...
The purchase of the Glidden Spina + Partners building in West Palm Beach for a Sackler family office took place in July 2020, less than two months before Purdue Pharma filed for Chapter 11 ...
He was erased," Patrick Radden Keefe wrote regarding Robert Sackler in his new book, "Empire of Pain." Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to ...
Say Nothing: A True Story of Murder and Memory in Northern Ireland is a 2018 book by writer and journalist Patrick Radden Keefe. It focuses on the Troubles in Northern Ireland. It spent six weeks on The New York Times Best Seller list and received widespread critical acclaim. It was adapted into a 2024 limited series for Hulu and Disney+.